obesity drug news today glp-1 september 22 2025 Innovent's weight-loss highlights China challenge for Novo, Lilly Unpacking $100B+ Obesity Market Opportunity:
Description
2017a;40:11724
FAQs What are GLP-1 natural alternatives, and how do they work
Food and Drug Administration announced it will take enforcement action against non-FDA-approved compounded GLP-1 drugs that are being mass-marketed as alternatives to FDA-approved therapies
Gallbladder problems , including gallstones, have also been associated with GLP-1 therapy, likely related to rapid weight loss and changes in bile composition
Assessment of pharmacological responses to an anti-diabetic drug in a new obese type 2 diabetic rat model
Unlike injectable GLP-1 medications, Orforglipron is taken orally and has shown encouraging early results
